Pricing Log in Create free account
Friday 6 November 2026 Export ENSG’s income statement to Excel — free account

The Ensign Group, Inc.

ENSG Healthcare Medical Care Facilities

The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.

Revenue
+14.5%
EPS
+23.6%
Free cash flow
+89.2%
Total debt
+39.2%

Quarter to September 2026, against a year earlier

180.91 1.48 −0.81%
Market cap
$10.6B
P/E
26.3×
Fwd P/E
25.4×
Dividend yield
0.14%
F-score
7/9
Altman Z
3.57
Beneish M
−2.57
Dividend safety
92/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Revenue by segment Fiscal 2022

  • Skilled Services
  • Standard Bearer
  • Other, not broken out

Every year since 2016 →

Insider Decisions last twelve months

Sold, $m 5.89
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell 2 2 7 1 3 1 1 3 — — 1 —
Insider Ownership 2.74%

Capital & Financial Ratios $m

Size
Market Cap 10,640.00
Revenue ttm 5,674.31
Net income ttm 399.51
Free cash flow ttm 509.91
Net debt Q (192.97)
Valuation
P/E 26.31
Forward P/E 25.40
Price / sales 1.85
Forward P/S Powerpack
Price / FCF 20.63
Price / book 4.10
Financial health
Current ratio Q 1.20
Debt / equity Q 0.08 (at or below 0.5: strong)
Interest coverage Q 60.36
Growth
Revenue growth Q +14.47% (above 0%: growing)
Operating income growth Q +43.41% (above 0%: growing)
EPS, this year +21.47% (at or above 15%: strong)
EPS, next year A +9.90%
Revenue, next year A +16.85% (at or above 10%: strong)
EPS, past 5 yrs +13.80%
EPS, next 5 yrs A +13.37%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.8×, against a ten-year median of 1.6×; over the ten years it ranged from 0.6× in 2016 to 2.3× in 2026.
P/E against its own 10 years 70.22%
10-year low 10-year high
P/S against its own 10 years 80.75%
10-year low 10-year high
P/B against its own 10 years 58.05%
10-year low 10-year high
EV/Sales against its own 10 years 82.03%
10-year low 10-year high
EV/FCF against its own 10 years 36.79%
10-year low 10-year high

Dividends raised 3 years running

Yield
0.14%
Annual rate
0.26
Payout ratio
3.87%
Growth, 2017–25
+5.75%/yr
  1. 0.16 ’17
  2. 0.17 ’18 +6
  3. 0.18 ’19 +7
  4. 0.20 ’20 +11
  5. 2.51 ’21 +1141
  6. 0.22 ’22 −91
  7. 0.23 ’23 +4
  8. 0.24 ’24 +4
  9. 0.25 ’25 +4
  10. 0.26 ’26e +5
paid forecast change on the year, % Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 527 527 572 392
Receivables 485 570 637 665
Inventory — — — —
Other — — — —
1,047 1,158 1,272 1,155
2023 2024 2025 Q'26
Payables 93 99 97 125
ST’ Debt 4 4 4 4
Other — — — —
735 743 894 963

Compound Annual Growth %

10y 5y 3y
Sales 14.19% 16.05% 18.68%
Cash Flow 32.68% 8.61% 27.46%
Earnings 20.03% 15.07% 15.25%
Book Value 18.00% 22.26% 21.41%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 1.94 Actual 2.03

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 1.75 1.82 Beat by 0.07
Q1 FY26 1.79 1.85 Beat by 0.06
Q2 FY26 1.80 1.92 Beat by 0.12
Q3 FY26 1.94 2.03 Beat by 0.09
Q4 FY26 2.12 — Reports 3 February 2027

EPS $

Mar Jun Sep Dec Year
’26 1.67 1.68 1.76 — —
’25 1.37 1.44 1.42 1.61 5.84
’24 1.19 1.22 1.34 1.36 5.12
’23 1.05 1.12 1.11 0.38 3.65
’22 0.89 1.01 0.99 1.06 3.95
’21 0.86 0.87 0.83 0.86 3.42
’20 0.73 0.73 0.77 0.82 3.06
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 1,389 1,440 1,484 — —
’25 1,173 1,228 1,296 1,361 5,058
’24 1,010 1,036 1,082 1,132 4,260
’23 887 921 941 980 3,729
’22 713 732 770 810 3,025
’21 627 639 669 693 2,627
’20 590 585 599 629 2,403
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 100 172 240 — —
’25 72 156 153 183 564
’24 35 77 134 100 347
’23 48 120 123 85 377
’22 46 84 93 50 273
’21 34 74 96 71 276
’20 27 147 108 91 373
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 65 119 193 — —
’25 29 106 102 133 371
’24 6 42 92 49 189
’23 22 95 98 56 270
’22 30 70 71 22 194
’21 20 56 80 53 208
’20 11 136 97 79 323
Fiscal quarters ending in the months shown.

Valuation

The price implies free cash flow after share-based pay growing 7.9% a year for ten years. It grew 55.6% a year over the last ten.

Implied
7.9%
10 years, reported
55.6%
Open the model

Target Price Range

Analyst price targets

Recommendation Rating

1.3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 1,655 1,598 1,755 2,037 2,403 2,627 3,025 3,729 4,260 5,058 5,674 +13.2% 5,910 6,626 7,236 +12.7%
Gross margin, % 11.39 10.82 12.46 14.29 16.96 17.82 17.12 15.84 15.67 15.81 16.57 +4.4 pt
EBT 86 31 72 116 218 258 289 273 386 456 533 +20.4%
EBT margin, % 5.19 1.95 4.09 5.70 9.06 9.82 9.56 7.31 9.06 9.01 9.38 +3.8 pt
Net income 53 41 93 112 171 198 225 210 298 344 400 +23.1%
Per share, $
Per share, $ Revenue 32.73 31.38 33.73 38.10 44.96 48.22 55.12 66.94 75.20 88.26 98.13 +11.7%
Earnings 0.99 0.79 1.78 2.07 3.19 3.57 4.09 3.76 5.26 6.00 6.92 +22.2%
Cash flow 1.46 1.56 4.04 3.60 6.99 5.06 4.97 6.76 6.13 9.85 12.03 +23.6%
Capex (0.49) (1.01) (0.89) (1.20) (0.93) (1.24) (1.44) (1.91) (2.79) (3.38) (3.21) +24.0%
Free cash flow 0.98 0.55 3.16 2.40 6.05 3.82 3.53 4.86 3.34 6.47 8.82 +23.4%
Book value 9.11 9.82 11.58 12.28 15.31 18.75 22.75 26.88 32.48 39.00 44.33 +17.5%
Shares, m 51 51 52 53 53 54 55 56 57 57 58 +1.4%
Valuation, ×
Valuation, × P/E 20.97 27.03 20.33 21.92 22.86 23.45 23.11 30.49 25.26 28.99 26.31 24.4
P/S 0.63 0.69 1.07 1.19 1.62 1.74 1.71 1.71 1.77 1.97 1.85 1.4
P/B 2.28 2.20 3.11 3.70 4.76 4.48 4.15 4.27 4.09 4.47 4.10 3.7
EV/Sales 0.76 0.85 1.18 1.31 1.57 1.70 1.66 1.61 1.68 1.89 1.82 1.4
EV/FCF 25.63 48.33 12.64 20.89 11.63 21.42 25.87 22.22 37.82 25.77 20.25 25.2
Cash, $m
Cash, $m Operating cash flow 74 80 210 192 373 276 273 377 347 564 696 +25.3%
Capex (25) (51) (46) (64) (50) (68) (79) (106) (158) (194) (186) +25.8%
Free cash flow 49 28 164 128 323 208 194 270 189 371 510 +25.1%
Balance, $m
Balance, $m Working capital 122 142 79 68 21 117 199 312 414 378 192 +13.4%
Net debt 214 258 204 251 (135) (119) (179) (377) (381) (431) (193) n/m
Shareholders’ equity 460 500 602 656 818 1,022 1,249 1,497 1,840 2,235 2,563 +19.2%
Returns, %
Returns, % ROA 5.72 3.85 8.09 6.24 6.95 7.21 7.13 5.49 6.74 6.79 7.11 +1.1 pt
ROIC 8.51 3.56 6.59 8.90 20.40 18.04 17.33 14.25 15.35 14.73 13.42 +6.2 pt
ROE 11.27 8.43 16.76 17.57 23.13 21.16 19.79 15.25 17.85 16.88 17.03 +5.6 pt
People
People Employees 19,482 21,301 23,463 24,500 24,400 25,900 29,900 35,300 39,300 46,000 — +10.0%
Revenue/emp, $m 0.08 0.08 0.07 0.08 0.10 0.10 0.10 0.11 0.11 0.11 — +2.9%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026

Business profile

Updated

The Ensign Group is a holding company whose independent subsidiaries provide skilled nursing, rehabilitation and senior living services. Skilled nursing facilities care for people who need nursing or rehabilitation after an illness or hospital stay, as well as people who need longer-term care. Residents include people recovering from strokes, respiratory or cardiovascular conditions, joint replacements and other disorders.

Care teams provide physician-prescribed nursing and therapy alongside room and board, nutritional programs and social services. Some facilities offer specialty care, including on-site dialysis, ventilator care and cardiac or pulmonary management. Senior living communities serve older adults who can live independently or need assistance with daily activities but do not require the same level of nursing care.

Where the money comes from and where it goes Fiscal 2022

Fiscal 2022: revenue by segment, and margins
Skilled Services 2,906 96.06%
Standard Bearer 73 2.41%
Other, not broken out 46 1.53%
Gross margin 17.12%
Operating margin 9.81%
Pre-tax margin 9.56%

Revenue by segment since 2016

The Ensign Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
EHC Encompass Health Corporation $13.9B 21.8× 20.9× +8.93% (above 0%: growing) +20.63% (above 0%: growing) +52.33% (above 0%: growing) 100.00% 17.89% Compare
FMS Fresenius Medical Care AG & Co. KGaA $12.6B 12.6× 14.4× −0.49% (below 0%: shrinking) −10.55% (below 0%: shrinking) −3.47% (below 0%: shrinking) 25.83% 7.78% Compare
DVA DaVita Inc. $12.3B 14.0× 13.0× +4.62% (above 0%: growing) +66.99% (above 0%: growing) −45.83% (below 0%: shrinking) 31.50% 13.95% Compare
UHS Universal Health Services, Inc. $11.7B 8.2× 8.0× +5.30% (above 0%: growing) −9.98% (below 0%: shrinking) +216.74% (above 0%: growing) 90.99% 9.60% Compare
ENSG The Ensign Group, Inc. $10.6B 26.3× 25.4× +14.47% (above 0%: growing) +23.64% (above 0%: growing) +89.21% (above 0%: growing) 16.86% 9.30%
PACS PACS Group, Inc. $8.0B 28.6× 21.8× +11.45% (above 0%: growing) +16.36% (above 0%: growing) −4.31% (below 0%: shrinking) 17.23% 6.65% Compare
CHE Chemed Corporation $7.0B 25.5× 24.0× +10.57% (above 0%: growing) +23.09% (above 0%: growing) −45.25% (below 0%: shrinking) 33.72% 13.96% Compare
CON Concentra Group Holdings Parent, Inc. $5.4B 24.9× 25.2× +8.61% (above 0%: growing) +36.84% (above 0%: growing) −19.76% (below 0%: shrinking) 31.42% 18.52% Compare
LFST LifeStance Health Group, Inc. $5.1B 70.7× 81.1× +25.30% (above 0%: growing) +2,042.86% (above 0%: growing) +31.57% (above 0%: growing) 0.00% 7.26% Compare
Median of peers $9.8B 23.4× 21.4× +8.77% +21.86% −3.89% 31.46% 11.78%

All 51 Medical Care Facilities stocks →

From the latest earnings call

Updated

  • CEO Barry Port said same-store occupancy reached 84.1% in the third quarter, while skilled-mix revenue rose across both same-store and transitioning facilities.
  • Port said recently acquired Florida facilities face clinical, financial and property challenges, and turnaround operations can take a year or more to contribute.

Largest institutional holders 13F, quarter to 30 June 2026

Held by institutions 90.52%
Held by the ten largest 50.07%
Holder Shares Stake Change
Vanguard 5.96m 10.23% −255.74k
BlackRock 5.85m 10.03% −1.52m
Baillie Gifford 5.03m 8.63% +203.10k
Fidelity (FMR) 2.54m 4.36% +243.89k
WASATCH ADVISORS LP 2.28m 3.91% +220.33k
Capital Group 2.02m 3.47% +617.60k
State Street 1.80m 3.08% −265.27k
Geode Capital Management 1.67m 2.86% −19.34k
Arrowstreet Capital 1.08m 1.84% +617.43k
Dimensional Fund Advisors 963.83k 1.65% +3.25k
13F filings for the quarter to 30 June 2026: long positions in US-listed shares reported by managers with $100m or more, ~45 days after the quarter.

Pay and ownership Proxy statement filed 2 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 13.80m 16.29m 241.38
2024 10.96m 11.51m 296.63
2023 11.05m 9.70m 250.09
2022 8.02m 8.00m 210.40
2021 7.42m 7.48m 186.25

Ownership

Directors and executive officers, together 4.00%
Blackrock, Inc. 12.20%
Baillie Gifford & Co 7.80%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

The Ensign Group, Inc. (ENSG) Latest News

3 Nov

Impact 3 · · MT Newswires

30 Oct

Impact 3 · · StockStory

29 Oct

Impact 4 · · The Motley Fool transcript
Impact 4 · · MarketBeat

28 Oct

Impact 4 · · StockStory
Impact 3 · · Associated Press
Impact 3 · · Moby

27 Oct

Impact 4 · · Investing.com earnings
Impact 3 · · Zacks
Impact 3 · · Zacks
Impact 3 · · StockStory

26 Oct

Impact 3 · · StockStory

23 Oct

Impact 3 · · GlobeNewswire

21 Oct

Impact 3 · · Zacks

19 Oct

Impact 3 · · Simply Wall St.

15 Oct

Impact 3 · · StockStory

6 Oct

Impact 4 · · Zacks
Impact 4 · · Business Wire

2 Oct

Impact 4 · · GlobeNewswire
Impact 4 · · GlobeNewswire
Impact 4 · · GlobeNewswire

21 Sep

Impact 3 ·

2 Sep

Impact 3 ·

20 Aug

Impact 3 ·

19 Aug

Impact 3 · · MarketBeat

31 Jul

Impact 3 ·

30 Jul

Impact 4 ·

29 Jul

Impact 4 · transcript
Impact 4 · · MarketBeat transcript

27 Jul

Impact 4 · · InvestorsHub

ENSG metrics, ten years each

stockrow.com/ENSG · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com